 To define the relative efficacy, safety and tolerability profiles of oral daily MBX-102 at daily doses of 400 and 600 mg vs. placebo and Actos 30 mg up-titrated to 45 mg after 8 weeks when administered for up to 24 weeks in patients inadequately controlled with a stable dose of metformin 1500 mgday. 